Category: Health Problems

Researchers identified a protein associated with breast cancer

Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies. High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said Dr. Weibo Luo, Assistant Professor of Pathology and Pharmacology, and with the

Just one concussion could raise Parkinson’s risk

If you’ve ever had a mild concussion, your risk of developing Parkinson’s disease goes up by 56 percent, a new study of more than 300,000 U.S. veterans suggests. “Upwards of 40 percent of adults have had a traumatic brain injury [concussion], so these findings are definitely concerning,” said study author Dr. Raquel Gardner. She is

Hypertension plus prediabetes a dangerous duo for the heart

High blood pressure and prediabetes together may do more harm to the body than either one alone. The first study of its type looking into the association between slightly elevated blood sugar levels and high blood pressure found that prediabetes didn’t increase cardiovascular risk by itself. But when researchers looked at prediabetes paired with high

Psoriasis treated with compound derived from immune cells

A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis. The compound suppresses an inflammatory pathway that is overactive in many autoimmune diseases, suggesting that it may be effective against multiple sclerosis, rheumatoid arthritis,

Targeting enzyme may tip cancer ‘over the edge’

Researchers from the University of Dundee have identified an enzyme critical for cell division that could potentially be targeted to tip tumours ‘over the edge’ into remission. A team led by Professor Paul Clarke and Dr. Adrian Saurin, from the University’s School of Medicine, discovered that the enzyme USP9X controls the proper timing of cell

Gender pay gap—personality affects income

Being high in ‘neuroticism’ and low in ‘conscientiousness’ can come at a cost in terms of income a new study has found. These effects were particularly strong for women, who benefited more than men for being conscientious but were penalised more than men for being neurotic. ‘Dark Triad’ & ‘Big Five’ personality traits influence income

Super-superbug clones invade Gulf States

A new wave of highly antibiotic resistant superbugs has been found in the Middle East Gulf States, discovered by University of Queensland researchers. UQ Centre for Clinical Research group leader Dr Hosam Zowawi said his team had witnessed rapid growth of the new multi-drug resistant clones – variants of existing superbugs in the Gulf States,

Preserving fertility during chemotherapy

Many chemotherapeutics act by damaging the DNA. Since cancer cells divide more often than most normal cells, they are more sensitive to DNA-damaging agents. One exception are oocytes. To prevent birth defects, they initiate a cellular death program if DNA damage is detected. This process, called apoptosis, is triggered in oocytes by the protein p63.

Could statins ease deadly heart condition in rare neuromuscular disease?

In preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich’s ataxia (FA), a widely used cholesterol-lowering drug increased a precursor of HDL (high-density lipoprotein), the “good cholesterol,” according to new research published in PLOS ONE from the Perelman School of Medicine at the University of Pennsylvania. Decreased HDL

Can a simple blood test rule out lung cancer?

Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients. Many are “incidentally detected,” meaning they are found during evaluation for an unrelated cause (for example, a chest X-ray after a fall). Although 75 to 85 percent of these incidentally detected nodules turn out to be benign,

FDA approves new standard of care for kidney cancer

The standard of care for kidney cancer patients continues to improve. The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer. The results of the large, international clinical trial leading to the approval were just published the prestigious New England

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like